These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


166 related items for PubMed ID: 36657936

  • 1. Docosahexaenoic acid (DHA) intake estimated from a 7-question survey identifies pregnancies most likely to benefit from high-dose DHA supplementation.
    Christifano DN, Crawford SA, Lee G, Brown AR, Camargo JT, Kerling EH, Gajewski BJ, Valentine CJ, Gustafson KM, DeFranco EA, Carlson SE.
    Clin Nutr ESPEN; 2023 Feb; 53():93-99. PubMed ID: 36657936
    [Abstract] [Full Text] [Related]

  • 2. Early and late preterm birth rates in participants adherent to randomly assigned high dose docosahexaenoic acid (DHA) supplementation in pregnancy.
    Carlson SE, Gajewski BJ, Valentine CJ, Sands SA, Brown AR, Kerling EH, Crawford SA, Buhimschi CS, Weiner CP, Cackovic M, DeFranco EA, Mudaranthakam DP, Rogers LK.
    Clin Nutr; 2023 Feb; 42(2):235-243. PubMed ID: 36680919
    [Abstract] [Full Text] [Related]

  • 3. Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol.
    Carlson SE, Gajewski BJ, Valentine CJ, Rogers LK, Weiner CP, DeFranco EA, Buhimschi CS.
    BMC Pregnancy Childbirth; 2017 Feb 13; 17(1):62. PubMed ID: 28193189
    [Abstract] [Full Text] [Related]

  • 4. ISSFAL statement number 7 - Omega-3 fatty acids during pregnancy to reduce preterm birth.
    Best KP, Gibson RA, Makrides M.
    Prostaglandins Leukot Essent Fatty Acids; 2022 Nov 13; 186():102495. PubMed ID: 36228573
    [Abstract] [Full Text] [Related]

  • 5. DHA, nutrient intake, and maternal characteristics as predictors of pregnancy outcomes in a randomised clinical trial of DHA supplementation.
    Wang Y, Gajewski BJ, Valentine CJ, Crawford SA, Brown AR, Mudaranthakam DP, Camargo JT, Carlson SE.
    Clin Nutr; 2023 Nov 13; 42(11):2229-2240. PubMed ID: 37806075
    [Abstract] [Full Text] [Related]

  • 6. Higher-Dose DHA Supplementation Modulates Immune Responses in Pregnancy and Is Associated with Decreased Preterm Birth.
    Valentine CJ, Khan AQ, Brown AR, Sands SA, Defranco EA, Gajewski BJ, Carlson SE, Reber KM, Rogers LK.
    Nutrients; 2021 Nov 26; 13(12):. PubMed ID: 34959801
    [Abstract] [Full Text] [Related]

  • 7. Omega-3 Fatty Acids and Maternal and Child Health: An Updated Systematic Review.
    Newberry SJ, Chung M, Booth M, Maglione MA, Tang AM, O'Hanlon CE, Wang DD, Okunogbe A, Huang C, Motala A, Trimmer M, Dudley W, Shanman R, Coker TR, Shekelle PG.
    Evid Rep Technol Assess (Full Rep); 2016 Oct 26; (224):1-826. PubMed ID: 30307735
    [Abstract] [Full Text] [Related]

  • 8. Plasma oxylipins and unesterified precursor fatty acids are altered by DHA supplementation in pregnancy: Can they help predict risk of preterm birth?
    Ramsden CE, Makrides M, Yuan ZX, Horowitz MS, Zamora D, Yelland LN, Best K, Jensen J, Taha AY, Gibson RA.
    Prostaglandins Leukot Essent Fatty Acids; 2020 Feb 26; 153():102041. PubMed ID: 31931275
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasma long-chain omega-3 fatty acid status and risk of recurrent early spontaneous preterm birth: a prospective observational study.
    Goodfellow L, Care A, Harrold J, Sharp A, Ivandic J, Poljak B, Roberts D, Alfirevic A, Müller-Myhsok B, Gibson R, Makrides M, Alfirevic Z.
    Acta Obstet Gynecol Scand; 2021 Aug 26; 100(8):1401-1411. PubMed ID: 33742474
    [Abstract] [Full Text] [Related]

  • 11. Omega-3 fatty acids to prevent preterm birth: Australian pregnant women's preterm birth awareness and intentions to increase omega-3 fatty acid intake.
    de Seymour JV, Simmonds LA, Gould J, Makrides M, Middleton P.
    Nutr J; 2019 Nov 14; 18(1):74. PubMed ID: 31727060
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Study protocol for a randomised controlled trial evaluating the effect of prenatal omega-3 LCPUFA supplementation to reduce the incidence of preterm birth: the ORIP trial.
    Zhou SJ, Best K, Gibson R, McPhee A, Yelland L, Quinlivan J, Makrides M.
    BMJ Open; 2017 Sep 24; 7(9):e018360. PubMed ID: 28947468
    [Abstract] [Full Text] [Related]

  • 15. A Prenatal DHA Test to Help Identify Women at Increased Risk for Early Preterm Birth: A Proposal.
    Jackson KH, Harris WS.
    Nutrients; 2018 Dec 06; 10(12):. PubMed ID: 30563193
    [Abstract] [Full Text] [Related]

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 17. Utility of a 7- question online screener for DHA intake.
    Christifano DN, Crawford SA, Lee G, Gajewski BJ, Carlson SE.
    Prostaglandins Leukot Essent Fatty Acids; 2022 Feb 01; 177():102399. PubMed ID: 35063885
    [Abstract] [Full Text] [Related]

  • 18. DHA supplementation and pregnancy outcomes.
    Carlson SE, Colombo J, Gajewski BJ, Gustafson KM, Mundy D, Yeast J, Georgieff MK, Markley LA, Kerling EH, Shaddy DJ.
    Am J Clin Nutr; 2013 Apr 01; 97(4):808-15. PubMed ID: 23426033
    [Abstract] [Full Text] [Related]

  • 19. Omega-3 fatty acid supply in pregnancy for risk reduction of preterm and early preterm birth.
    Cetin I, Carlson SE, Burden C, da Fonseca EB, di Renzo GC, Hadjipanayis A, Harris WS, Kumar KR, Olsen SF, Mader S, McAuliffe FM, Muhlhausler B, Oken E, Poon LC, Poston L, Ramakrishnan U, Roehr CC, Savona-Ventura C, Smuts CM, Sotiriadis A, Su KP, Tribe RM, Vannice G, Koletzko B, Clinical Practice Guideline on behalf of Asia Pacific Health Association (Pediatric-Neonatology Branch), Child Health Foundation (Stiftung Kindergesundheit), European Academy of Paediatrics, European Board & College of Obstetrics and Gynaecology, European Foundation for the Care of Newborn Infants, European Society for Paediatric Research, and International Society for Developmental Origins of Health and Disease.
    Am J Obstet Gynecol MFM; 2024 Feb 01; 6(2):101251. PubMed ID: 38070679
    [Abstract] [Full Text] [Related]

  • 20. Predicting the effect of maternal docosahexaenoic acid (DHA) supplementation to reduce early preterm birth in Australia and the United States using results of within country randomized controlled trials.
    Yelland LN, Gajewski BJ, Colombo J, Gibson RA, Makrides M, Carlson SE.
    Prostaglandins Leukot Essent Fatty Acids; 2016 Sep 01; 112():44-9. PubMed ID: 27637340
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.